Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Cash flows from operating activities
Net loss	$ (5,913,892)	$ (2,955,079)
Adjustments for non-cash income and expenses:
Depreciation	50,074	137,106
Amortization	1,804,838	2,078,694
Stock based expense	3,261,676
Changes in operating assets and liabilities:
Accounts receivables	4,944	1,444
Inventories	79,394	(94,838)
Deposit, prepayments and advances to suppliers	26,788	128,099
Operating lease right-of-use assets	51,299	41,049
Accounts payable and accruals	(105,622)	81,853
Deferred revenue	(1,325)	(40,296)
Operating lease liabilities	(51,409)	(43,128)
Other payables	54,840	(48)
Amounts due to shareholders	749,086	207,535
Net cash generated from/(used in) operations	10,691	(457,609)
Cash flows from investing activity
Purchase of property, plant and equipment		(96,186)
Cash used in investing activity		(96,186)
Cash flows from financing activities
Payments of hire purchase	(4,358)	(4,144)
Net cash used in financing activities	(4,358)	(4,144)
Net increase/(decrease) in cash and cash equivalents	6,333	(557,939)
Effect of exchange rate changes	40,143	(84,081)
Cash and cash equivalents at start of period	152,985	779,049
Cash and cash equivalents at end of period	199,461	137,029
Supplemental disclosure of non-cash investing and financing information :
Common stock issued for consulting service in relation to initial public offering	$ 2,718,064